US 10258573
Micronized insulin and micronized insulin analogues prepared under acidic conditions, and methods of manufacturing the same under acidic conditions
granted A61KA61K38/28A61K9/0075
Quick answer
US patent 10258573 (Micronized insulin and micronized insulin analogues prepared under acidic conditions, and methods of manufacturing the same under acidic conditions) held by Amphastar Pharmaceuticals, Inc. expires Mon Apr 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Amphastar Pharmaceuticals, Inc.
- Grant date
- Tue Apr 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K38/28, A61K9/0075, A61K9/008, A61K9/14